23,338,039
Vote Records
27,979
Companies
11,817
Funds
4,051
Managers

Home › Companies › ImmunityBio, Inc. › 2025-2026

ImmunityBio, Inc. 2025-2026 Proxy Voting Records

At ImmunityBio, Inc.'s shareholder meeting held June 9, 2026, in the 2025-2026 proxy season, 57 asset managers reported how they voted on 10 ballot items in their SEC Form N-PX filings, covering 1,868 separate fund positions. On the most widely held item on that ballot — Election of Directors: Barry J. Simon, M.D. — ImmunityBio, Inc.'s filing reports the nominee as elected, with 99.7% support of the votes cast (FOR divided by FOR plus WITHHELD, because this ballot offered only for and withhold; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: ImmunityBio, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 10, 2026.

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and ImmunityBio, Inc.’s Form 8-K, filed June 10, 2026 (Item 5.07 on EDGAR). Page generated November 8, 2026.

  • 10Ballot items
  • 57Asset managers
  • 1,868Fund votes
  • June 9, 2026Meeting date

Results at a glance

Meeting of June 9, 2026: 10 items on ImmunityBio, Inc.’s Form 8-K, filed June 10, 2026: 9 elected · 1 approved.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2025-2026

Explore ImmunityBio, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by ImmunityBio, Inc.

These tallies are ImmunityBio, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 10, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

ImmunityBio, Inc. — official shareholder meeting results, meeting held June 9, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Patrick Soon-Shiong, M.D. 714,631,732---- 19,014,153151,521,174 97%Elected—
Elect Director: Cheryl L. Cohen 731,554,649---- 2,091,236151,521,174 99.7%Elected—
Elect Director: Richard Adcock 731,960,821---- 1,685,064151,521,174 99.7%Elected—
Elect Director: Michael D. Blaszyk 722,575,150---- 11,070,735151,521,174 98%Elected—
Elect Director: Wesley Clark 729,527,285---- 4,118,600151,521,174 99.4%Elected—
Elect Director: Linda Maxwell, M.D. 717,976,024---- 15,669,861151,521,174 98%Elected—
Elect Director: Christobel Selecky 722,387,537---- 11,258,348151,521,174 98%Elected—
Elect Director: Barry J. Simon, M.D. 731,770,436---- 1,875,449151,521,174 99.7%Elected—
Elect Director: Bruce Wendel 732,149,734---- 1,496,151151,521,174 99.7%Elected—
2. Ratification of Appointment of Independent Registered Public Accounting Firm 882,420,1391,675,9601,070,960 ---- 99.8%Approved—

Source: ImmunityBio, Inc., Form 8-K, filed with the SEC on June 10, 2026 — read the filing on EDGAR.

How asset managers voted at the ImmunityBio, Inc. 2025-2026 meeting

Each item below shows how the 57 asset managers that disclosed a ImmunityBio, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Barry J. Simon, M.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 731,770,436WITHHELD: 1,875,449
Details: description as filed, official tally, votes by 57 asset managers

Description as filed by funds: Election of Directors: Barry J. Simon, M.D.

ImmunityBio, Inc.’s own tally for this item (“Elect Director: Barry J. Simon, M.D.”): 731,770,436 for, 1,875,449 withheld, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were re-elected by the holders of our Common Stock to serve as directors for a one year term expiring at the 2027 annual meeting of stockholders based on the following results of voting.”
Support: 99.7% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 57 asset managers below reported 8,805,025 for, 219,772 withheld, 2 abstained.

FOR
FOR: 8,805,025ABSTAIN: 2WITHHOLD: 219,772
Largest asset managers voting on “Election of Directors: Barry J. Simon, M.D.” at ImmunityBio, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
State Street2,615,5340 03,442For
Vanguard2,057,9320 22,599For
BlackRock806,8450 00For
Bridge Builder Trust395,4310 00For
WP Trust360,0000 00For
Lincoln Financial310,5700 00For
Equitable306,6290 00For
Charles Schwab275,1290 00For
Fidelity246,2970 00For
Putnam00 0199,289Withhold
HUSSMAN INVESTMENT TRUST180,0000 00For
Elevation Series Trust166,2310 00For
First Trust158,8800 00For
Ultimus Managers Trust103,2670 00For
AIG/SunAmerica81,9110 00For
Federated Hermes77,6160 00For
AQR74,9850 00For
TIAA63,6940 00For
John Hancock63,1950 00For
Direxion Shares ETF Trust60,2580 00For
SEI48,5140 00For
DWS41,2970 00For
QUANTITATIVE MASTER SERIES LLC37,2500 00For
Global X36,6060 00For
Venerable Variable Insurance Trust31,7830 00For

Showing the 25 largest of 57 asset managers. All 57 are in the interactive database (link above).

2. Elect Director: Bruce Wendel

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 732,149,734WITHHELD: 1,496,151
Details: description as filed, official tally, votes by 57 asset managers

Description as filed by funds: Election of Directors: Bruce Wendel

ImmunityBio, Inc.’s own tally for this item (“Elect Director: Bruce Wendel”): 732,149,734 for, 1,496,151 withheld, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were re-elected by the holders of our Common Stock to serve as directors for a one year term expiring at the 2027 annual meeting of stockholders based on the following results of voting.”
Support: 99.7% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 57 asset managers below reported 8,812,852 for, 211,946 withheld, 1 abstained.

FOR
FOR: 8,812,852ABSTAIN: 1WITHHOLD: 211,946
Largest asset managers voting on “Election of Directors: Bruce Wendel” at ImmunityBio, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
State Street2,618,9760 00For
Vanguard2,060,5320 10For
BlackRock806,8450 00For
Bridge Builder Trust395,4310 00For
WP Trust360,0000 00For
Lincoln Financial310,5700 00For
Equitable306,6290 00For
Charles Schwab275,1290 00For
Fidelity246,2970 00For
Putnam00 0199,289Withhold
HUSSMAN INVESTMENT TRUST180,0000 00For
Elevation Series Trust166,2310 00For
First Trust158,8800 00For
Ultimus Managers Trust103,2670 00For
AIG/SunAmerica81,9110 00For
Federated Hermes77,6160 00For
AQR74,9850 00For
TIAA63,6940 00For
John Hancock63,1950 00For
Direxion Shares ETF Trust60,2580 00For
SEI48,5140 00For
DWS41,2970 00For
QUANTITATIVE MASTER SERIES LLC37,2500 00For
Global X36,6060 00For
Venerable Variable Insurance Trust31,7830 00For

Showing the 25 largest of 57 asset managers. All 57 are in the interactive database (link above).

3. Elect Director: Cheryl L. Cohen

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 731,554,649WITHHELD: 2,091,236
Details: description as filed, official tally, votes by 57 asset managers

Description as filed by funds: Election of Directors: Cheryl L. Cohen

ImmunityBio, Inc.’s own tally for this item (“Elect Director: Cheryl L. Cohen”): 731,554,649 for, 2,091,236 withheld, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were re-elected by the holders of our Common Stock to serve as directors for a one year term expiring at the 2027 annual meeting of stockholders based on the following results of voting.”
Support: 99.7% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 57 asset managers below reported 8,751,894 for, 235,903 withheld, 2 abstained.

FOR
FOR: 8,751,894ABSTAIN: 2WITHHOLD: 235,903
Largest asset managers voting on “Election of Directors: Cheryl L. Cohen” at ImmunityBio, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
State Street2,618,9760 00For
Vanguard2,060,5310 20For
BlackRock806,8450 00For
Bridge Builder Trust395,4310 00For
WP Trust360,0000 00For
Lincoln Financial310,5700 00For
Equitable306,6290 00For
Charles Schwab275,1290 00For
Fidelity246,2970 00For
Putnam00 0199,289Withhold
Elevation Series Trust166,2310 00For
First Trust158,8800 00For
HUSSMAN INVESTMENT TRUST143,0000 00For
Ultimus Managers Trust103,2670 00For
AIG/SunAmerica81,9110 00For
Federated Hermes77,6160 00For
AQR74,9850 00For
TIAA63,6940 00For
John Hancock63,1950 00For
Direxion Shares ETF Trust60,2580 00For
SEI48,5140 00For
DWS41,2970 00For
QUANTITATIVE MASTER SERIES LLC37,2500 00For
Global X36,6060 00For
Venerable Variable Insurance Trust31,7830 00For

Showing the 25 largest of 57 asset managers. All 57 are in the interactive database (link above).

4. Elect Director: Christobel Selecky

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 722,387,537WITHHELD: 11,258,348
Details: description as filed, official tally, votes by 57 asset managers

Description as filed by funds: Election of Directors: Christobel Selecky

ImmunityBio, Inc.’s own tally for this item (“Elect Director: Christobel Selecky”): 722,387,537 for, 11,258,348 withheld, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were re-elected by the holders of our Common Stock to serve as directors for a one year term expiring at the 2027 annual meeting of stockholders based on the following results of voting.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 57 asset managers below reported 8,128,797 for, 895,984 withheld, 18 abstained.

FOR
FOR: 8,128,797ABSTAIN: 18WITHHOLD: 895,984
Largest asset managers voting on “Election of Directors: Christobel Selecky” at ImmunityBio, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
State Street2,612,4830 06,493For
Vanguard2,057,9160 182,599For
BlackRock806,8450 00For
Bridge Builder Trust395,4310 00For
WP Trust360,0000 00For
Lincoln Financial223,4970 087,073Mixed
Equitable306,6290 00For
Charles Schwab275,1290 00For
Fidelity246,2970 00For
Putnam00 0199,289Withhold
HUSSMAN INVESTMENT TRUST180,0000 00For
Elevation Series Trust166,2310 00For
First Trust00 0158,880Withhold
Ultimus Managers Trust103,2670 00For
AIG/SunAmerica00 081,911Withhold
Federated Hermes77,6160 00For
AQR00 074,985Withhold
TIAA63,6940 00For
John Hancock00 063,195Withhold
Direxion Shares ETF Trust00 060,258Withhold
SEI48,5140 00For
DWS00 041,297Withhold
QUANTITATIVE MASTER SERIES LLC37,2500 00For
Global X36,6060 00For
Venerable Variable Insurance Trust21,8010 09,982Mixed

Showing the 25 largest of 57 asset managers. All 57 are in the interactive database (link above).

5. Elect Director: Linda Maxwell, M.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 717,976,024WITHHELD: 15,669,861
Details: description as filed, official tally, votes by 57 asset managers

Description as filed by funds: Election of Directors: Linda Maxwell, M.D.

ImmunityBio, Inc.’s own tally for this item (“Elect Director: Linda Maxwell, M.D.”): 717,976,024 for, 15,669,861 withheld, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were re-elected by the holders of our Common Stock to serve as directors for a one year term expiring at the 2027 annual meeting of stockholders based on the following results of voting.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 57 asset managers below reported 6,828,340 for, 2,196,438 withheld, 21 abstained.

FORWITHHOLD
FOR: 6,828,340ABSTAIN: 21WITHHOLD: 2,196,438
Largest asset managers voting on “Election of Directors: Linda Maxwell, M.D.” at ImmunityBio, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
State Street2,612,4830 06,493For
Vanguard2,057,9130 212,599For
BlackRock135,3990 0671,446Mixed
Bridge Builder Trust324,8540 070,577Mixed
WP Trust360,0000 00For
Lincoln Financial198,0000 0112,570Mixed
Equitable00 0306,629Withhold
Charles Schwab275,1290 00For
Fidelity91,0910 0155,206Mixed
Putnam00 0199,289Withhold
HUSSMAN INVESTMENT TRUST180,0000 00For
Elevation Series Trust166,2310 00For
First Trust00 0158,880Withhold
Ultimus Managers Trust103,2670 00For
AIG/SunAmerica00 081,911Withhold
Federated Hermes77,6160 00For
AQR00 074,985Withhold
TIAA63,6940 00For
John Hancock00 063,195Withhold
Direxion Shares ETF Trust00 060,258Withhold
SEI48,5140 00For
DWS00 041,297Withhold
QUANTITATIVE MASTER SERIES LLC00 037,250Withhold
Global X36,6060 00For
Venerable Variable Insurance Trust21,8010 09,982Mixed

Showing the 25 largest of 57 asset managers. All 57 are in the interactive database (link above).

6. Elect Director: Michael D. Blaszyk

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 722,575,150WITHHELD: 11,070,735
Details: description as filed, official tally, votes by 57 asset managers

Description as filed by funds: Election of Directors: Michael D. Blaszyk

ImmunityBio, Inc.’s own tally for this item (“Elect Director: Michael D. Blaszyk”): 722,575,150 for, 11,070,735 withheld, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were re-elected by the holders of our Common Stock to serve as directors for a one year term expiring at the 2027 annual meeting of stockholders based on the following results of voting.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 57 asset managers below reported 8,127,492 for, 897,289 withheld, 18 abstained.

FOR
FOR: 8,127,492ABSTAIN: 18WITHHOLD: 897,289
Largest asset managers voting on “Election of Directors: Michael D. Blaszyk” at ImmunityBio, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
State Street2,612,4830 06,493For
Vanguard2,056,6110 183,904For
BlackRock806,8450 00For
Bridge Builder Trust395,4310 00For
WP Trust360,0000 00For
Lincoln Financial223,4970 087,073Mixed
Equitable306,6290 00For
Charles Schwab275,1290 00For
Fidelity246,2970 00For
Putnam00 0199,289Withhold
HUSSMAN INVESTMENT TRUST180,0000 00For
Elevation Series Trust166,2310 00For
First Trust00 0158,880Withhold
Ultimus Managers Trust103,2670 00For
AIG/SunAmerica00 081,911Withhold
Federated Hermes77,6160 00For
AQR00 074,985Withhold
TIAA63,6940 00For
John Hancock00 063,195Withhold
Direxion Shares ETF Trust00 060,258Withhold
SEI48,5140 00For
DWS00 041,297Withhold
QUANTITATIVE MASTER SERIES LLC37,2500 00For
Global X36,6060 00For
Venerable Variable Insurance Trust21,8010 09,982Mixed

Showing the 25 largest of 57 asset managers. All 57 are in the interactive database (link above).

7. Elect Director: Patrick Soon-Shiong, M.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 714,631,732WITHHELD: 19,014,153
Details: description as filed, official tally, votes by 57 asset managers

Description as filed by funds: Election of Directors: Patrick Soon-Shiong, M.D.

ImmunityBio, Inc.’s own tally for this item (“Elect Director: Patrick Soon-Shiong, M.D.”): 714,631,732 for, 19,014,153 withheld, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were re-elected by the holders of our Common Stock to serve as directors for a one year term expiring at the 2027 annual meeting of stockholders based on the following results of voting.”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 57 asset managers below reported 5,090,811 for, 3,896,970 withheld, 18 abstained.

FORWITHHOLD
FOR: 5,090,811ABSTAIN: 18WITHHOLD: 3,896,970
Largest asset managers voting on “Election of Directors: Patrick Soon-Shiong, M.D.” at ImmunityBio, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
State Street1,9030 02,617,073Withhold
Vanguard2,056,6110 183,904For
BlackRock806,8450 00For
Bridge Builder Trust395,4310 00For
WP Trust360,0000 00For
Lincoln Financial25,4970 0285,073Mixed
Equitable306,6290 00For
Charles Schwab275,1290 00For
Fidelity246,2970 00For
Putnam00 0199,289Withhold
Elevation Series Trust166,2310 00For
First Trust00 0158,880Withhold
HUSSMAN INVESTMENT TRUST143,0000 00For
Ultimus Managers Trust00 0103,267Withhold
AIG/SunAmerica00 081,911Withhold
Federated Hermes77,6160 00For
AQR00 074,985Withhold
TIAA00 063,694Withhold
John Hancock00 063,195Withhold
Direxion Shares ETF Trust00 060,258Withhold
SEI48,5140 00For
DWS00 041,297Withhold
QUANTITATIVE MASTER SERIES LLC37,2500 00For
Global X36,6060 00For
Venerable Variable Insurance Trust21,8010 09,982Mixed

Showing the 25 largest of 57 asset managers. All 57 are in the interactive database (link above).

8. Elect Director: Richard Adcock

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 731,960,821WITHHELD: 1,685,064
Details: description as filed, official tally, votes by 57 asset managers

Description as filed by funds: Election of Directors: Richard Adcock

ImmunityBio, Inc.’s own tally for this item (“Elect Director: Richard Adcock”): 731,960,821 for, 1,685,064 withheld, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were re-elected by the holders of our Common Stock to serve as directors for a one year term expiring at the 2027 annual meeting of stockholders based on the following results of voting.”
Support: 99.7% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 57 asset managers below reported 8,805,025 for, 219,772 withheld, 2 abstained.

FOR
FOR: 8,805,025ABSTAIN: 2WITHHOLD: 219,772
Largest asset managers voting on “Election of Directors: Richard Adcock” at ImmunityBio, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
State Street2,615,5340 03,442For
Vanguard2,057,9320 22,599For
BlackRock806,8450 00For
Bridge Builder Trust395,4310 00For
WP Trust360,0000 00For
Lincoln Financial310,5700 00For
Equitable306,6290 00For
Charles Schwab275,1290 00For
Fidelity246,2970 00For
Putnam00 0199,289Withhold
HUSSMAN INVESTMENT TRUST180,0000 00For
Elevation Series Trust166,2310 00For
First Trust158,8800 00For
Ultimus Managers Trust103,2670 00For
AIG/SunAmerica81,9110 00For
Federated Hermes77,6160 00For
AQR74,9850 00For
TIAA63,6940 00For
John Hancock63,1950 00For
Direxion Shares ETF Trust60,2580 00For
SEI48,5140 00For
DWS41,2970 00For
QUANTITATIVE MASTER SERIES LLC37,2500 00For
Global X36,6060 00For
Venerable Variable Insurance Trust31,7830 00For

Showing the 25 largest of 57 asset managers. All 57 are in the interactive database (link above).

9. Elect Director: Wesley Clark

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%
FOR: 729,527,285WITHHELD: 4,118,600
Details: description as filed, official tally, votes by 57 asset managers

Description as filed by funds: Election of Directors: Wesley Clark

ImmunityBio, Inc.’s own tally for this item (“Elect Director: Wesley Clark”): 729,527,285 for, 4,118,600 withheld, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were re-elected by the holders of our Common Stock to serve as directors for a one year term expiring at the 2027 annual meeting of stockholders based on the following results of voting.”
Support: 99.4% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 57 asset managers below reported 8,677,797 for, 346,996 withheld, 6 abstained.

FOR
FOR: 8,677,797ABSTAIN: 6WITHHOLD: 346,996
Largest asset managers voting on “Election of Directors: Wesley Clark” at ImmunityBio, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
State Street2,615,5340 03,442For
Vanguard2,057,9280 62,599For
BlackRock806,8450 00For
Bridge Builder Trust395,4310 00For
WP Trust360,0000 00For
Lincoln Financial310,5700 00For
Equitable306,6290 00For
Charles Schwab275,1290 00For
Fidelity246,2970 00For
Putnam00 0199,289Withhold
HUSSMAN INVESTMENT TRUST180,0000 00For
Elevation Series Trust166,2310 00For
First Trust158,8800 00For
Ultimus Managers Trust00 0103,267Withhold
AIG/SunAmerica81,9110 00For
Federated Hermes77,6160 00For
AQR74,9850 00For
TIAA63,6940 00For
John Hancock63,1950 00For
Direxion Shares ETF Trust60,2580 00For
SEI48,5140 00For
DWS41,2970 00For
QUANTITATIVE MASTER SERIES LLC37,2500 00For
Global X36,6060 00For
Venerable Variable Insurance Trust31,7830 00For

Showing the 25 largest of 57 asset managers. All 57 are in the interactive database (link above).

10. Ratification of Appointment of Independent Registered Public Accounting Firm

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 3 wordings of this item as funds reported it.

99.8% Approved · of votes cast

FOR 99.8%
FOR: 882,420,139AGAINST: 1,675,960
Details: description as filed, official tally, votes by 57 asset managers

Description as filed by funds: To ratify the selection of Deloitte & Touche LLP as ImmunityBio's independent registered public accounting firm for the fiscal year ending December 31, 2026.

ImmunityBio, Inc.’s own tally for this item (“2. Ratification of Appointment of Independent Registered Public Accounting Firm”): 882,420,139 for, 1,675,960 against — passed, per its Form 8-K filed June 10, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified by our stockholders based on the following results of voting:”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 57 asset managers below reported 8,908,874 for, 103,268 against, 12,657 abstained.

FOR
FOR: 8,908,874AGAINST: 103,268ABSTAIN: 12,657
Largest asset managers voting on “To ratify the selection of Deloitte & Touche LLP as ImmunityBio's independent registered public accounting fir” at ImmunityBio, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
State Street2,618,9760 00For
Vanguard2,060,5321 00For
BlackRock806,8450 00For
Bridge Builder Trust395,4310 00For
WP Trust360,0000 00For
Lincoln Financial310,5700 00For
Equitable306,6290 00For
Charles Schwab275,1290 00For
Fidelity246,2970 00For
Putnam199,2890 00For
HUSSMAN INVESTMENT TRUST180,0000 00For
Elevation Series Trust166,2310 00For
First Trust158,8800 00For
Ultimus Managers Trust0103,267 00Against
AIG/SunAmerica81,9110 00For
Federated Hermes77,6160 00For
AQR74,9850 00For
TIAA63,6940 00For
John Hancock63,1950 00For
Direxion Shares ETF Trust60,2580 00For
SEI48,5140 00For
DWS41,2970 00For
QUANTITATIVE MASTER SERIES LLC37,2500 00For
Global X36,6060 00For
Venerable Variable Insurance Trust31,7830 00For

Showing the 25 largest of 57 asset managers. All 57 are in the interactive database (link above).

Largest ImmunityBio, Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 1,047,353,977 shares outstanding at the time of that meeting.

Fund voting reports: top ImmunityBio, Inc. shareholders by shares voted on “Election of Directors: Barry J. Simon, M.D.”, 2025-2026
#Asset manager % of shares outstanding
1State Street 0.25%
2Vanguard 0.20%
3BlackRock 0.08%
4Bridge Builder Trust 0.04%
5WP Trust 0.03%
6Lincoln Financial 0.03%
7Equitable 0.03%
8Charles Schwab 0.03%
9Fidelity 0.02%
10Putnam 0.02%
Institutional-manager reports: top ImmunityBio, Inc. shareholders by shares voted on “Election of Directors: Barry J. Simon, M.D.”, 2025-2026
#Asset manager % of shares outstanding
1Berkeley Capital Partners, LLC <0.01%

Reported ImmunityBio, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

ImmunityBio, Inc. holdings and ownership disclosed for the 2025-2026 proxy season
Holder % outstanding Disclosure
Patrick Soon-Shiong — 13D
Nant Capital, LLC — DEF14A
Cambridge Equities, LP — DEF14A
California Capital Equity, LLC — DEF14A
NantWorks, LLC — DEF14A
Vanguard Group — 13F
BlackRock — 13F
State Street — 13F
D.E. Shaw — 13F
Geode Capital — 13F

Percentages above are of 1,047,353,977 shares outstanding, as reported by ImmunityBio, Inc. on its Form 10-Q dated May 5, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ImmunityBio, Inc.’s 10-Q dated May 5, 2026. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.

ImmunityBio, Inc. proxy season coverage: 2023-2024 · 2025-2026 (this page).

Cite this page

proxyvotesnow.com, “ImmunityBio (IBRX) 2026 Annual Meeting: Vote Results & How Funds Voted”, https://proxyvotesnow.com/company/immunitybio-inc/2026 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.